artificial intelligence (AI)

The collaboration aims to turn scientific discoveries into practical healthcare solutions by combining MIT’s research expertise with Abu Dhabi’s expanding life sciences ecosystem.

The initiative brings together SK bioscience, global health nonprofit PATH, consulting firm Slalom and technology partner SK AX to create an evidence-based system that helps researchers evaluate vaccine candidates before they enter costly late-stage clinical trials.

Researchers can use the platform to design CRISPR screening experiments, analyse single-cell RNA sequencing data and generate three-dimensional protein structures, chemistry drawings and genome browser tracks.

The agreement brings together Lilly’s expertise in developing innovative medicines with Abu Dhabi’s advanced healthcare infrastructure, population-scale health data, and genomics capabilities.

BrightHeart will officially introduce the platform to European clinicians during the Fetal Medicine Foundation (FMF) World Congress in Vienna, taking place from June 28 to July 2, 2026.

Moscow researchers developed a series of national standards, known as GOST standards, covering the creation, testing, and clinical use of AI technologies.

The analysis showed that the best results were achieved when AI acted as a “second reader,” supporting physicians rather than replacing them.

The agreement brings together Protillion’s computational biology platform with Merck’s established drug development expertise to support the discovery of next-generation therapies.

The publications aim to support the growing integration of AI into medical imaging and to strengthen clinicians’ ability to use these technologies safely and effectively in everyday practice.

Since 2020, the Moscow government has been running the Moscow Experiment on Computer Vision in healthcare, an initiative coordinated by the Center for Diagnostics and Telemedicine with support from the city’s digital infrastructure teams.